mixed amphetamine salts XR
Selected indexed studies
- Stimulant therapy in the management of ADHD: mixed amphetamine salts (extended release). (Expert Opin Pharmacother, 2007) [PMID:17714065]
- Safety, efficacy and extended duration of action of mixed amphetamine salts extended-release capsules for the treatment of ADHD. (Expert Opin Pharmacother, 2005) [PMID:15952928]
- Mixed-amphetamine salts increase abstinence from marijuana in patients with co-occurring attention-deficit/hyperactivity disorder and cocaine dependence. (Am J Addict, 2016) [PMID:28051838]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Stimulant therapy in the management of ADHD: mixed amphetamine salts (extended release). (2007) pubmed
- Safety, efficacy and extended duration of action of mixed amphetamine salts extended-release capsules for the treatment of ADHD. (2005) pubmed
- Mixed-amphetamine salts increase abstinence from marijuana in patients with co-occurring attention-deficit/hyperactivity disorder and cocaine dependence. (2016) pubmed
- Mixed amphetamine salts extended-release in the treatment of adult ADHD: a randomized, controlled trial. (2006) pubmed
- Single- and multiple-dose pharmacokinetics of an oral mixed amphetamine salts extended-release formulation in adults. (2005) pubmed
- The mixed amphetamine salt extended release (Adderall XR, Max-XR) as an adjunctive to SSRIS or SNRIS in the treatment of adult ADHD patients with comorbid partially responsive generalized anxiety: an open-label study. (2010) pubmed
- Bioavailability of triple-bead mixed amphetamine salts compared with a dose-augmentation strategy of mixed amphetamine salts extended release plus mixed amphetamine salts immediate release. (2007) pubmed
- Efficacy and safety of mixed amphetamine salts extended release (adderall XR) in the management of oppositional defiant disorder with or without comorbid attention-deficit/hyperactivity disorder in school-aged children and adolescents: A 4-week, multicenter, randomized, double-blind, parallel-group, placebo-controlled, forced-dose-escalation study. (2006) pubmed
- Long-term tolerability and effectiveness of once-daily mixed amphetamine salts (Adderall XR) in children with ADHD. (2005) pubmed
- Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study. (2006) pubmed